Michigan Institute for Clinical and Health Research (MCHR)

2007年CTSA对密歇根临床与健康研究所(MICHR)的资助标志着密歇根大学(UM)临床-翻译研究(CTR)转型的开始。这一奖项，加上强有力的机构支持和日益增长的教职员工参与度，使密歇根大学从一家以基础科学研究为主的机构发展成为一家拥有全面研究组合的机构。这是在以下基础上实现的：整合和创新的培训和教育计划，已接触到近2,000名受训人员、教职员工；集中和优化以前分散的研究服务，为用户创造创新机会；分发1020万美元用于试点研究，以加快创新；以及研究人员参与与我们的社区和整个CTSA国家联盟的新伙伴关系。在续展期间，CTSA资金加上强有力的机构支持，将使MICHR能够实现5个首要目标：1)优化培训和指导，以创建下一代研究团队以及临床和翻译研究人员；2)加强基础设施和完善研究服务，以减少障碍，最大限度地提高整个翻译研究的研究效率；3)促进合作，并利用创新的方法和技术促进发现；4)加强社区和实践合作伙伴关系，以确保双向学习、研究和实施研究成果，以造福健康；5)积极领导和促进国家CTSA联盟活动，并参与跨CTSA合作。这些将通过以下方式实现：将教育扩展到新的领域，以加强CTR调查人员的渠道，并部署更灵活的培训工具；加强现有服务，并推出新的服务，以影响研究的启动时间和招聘；利用重大的信息学投资，将CTR调查人员的需求完全纳入IT领域；利用新的以实践为基础的研究网络；扩大评估，以有效地评估和优化我们的业绩。MICHR将成为高质量、高影响的临床和转化性研究的改进和创新的引擎，以促进密歇根州和全国的健康。

The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff; centralization and optimization of previously fragmented research services to create innovative opportunities for users; $10.2M distributed for pilot studies to accelerate innovation; and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators; 2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum; 3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery; 4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health; 5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools; strengthening existing services and launching new ones to impact study start-up times and recruitment; employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape; utilizing new practice-based research networks; expanding evaluation to efficiently assess and optimize our performance. MICHR will be the engine of improvement and innovation in the conduct of high-quality, high impact-clinical and translational research to advance the health of Michigan and the nation.